Nicotinamide Mononucleotide, beta-NMN
The Book of Peptides is not a clinic and not your doctor. We do not sell, prescribe, recommend, or personalize any compound, and no grade or ranking here is an endorsement. None of the compounds covered are approved for the uses described here by the U.S. FDA, Australia's Therapeutic Goods Administration (TGA), New Zealand's Medsafe, or the equivalent regulator in most other countries.
Most are sold for laboratory research only, a few are prescription-only drugs, and some are controlled substances or banned in sport. Possessing or administering an unapproved compound outside an authorized setting may be unlawful wherever you live. Nothing here is a recommendation to buy, possess, or self-administer anything. Consult a licensed physician before any decision involving peptide use.
Cross-checked against 50–100 independent sources per claim — the house standard. How this reference is checked
NMN is a direct NAD+ precursor and one of the best-selling longevity supplements, distinct from NAD+ itself in that it is orally bioavailable, cheaper, and needs no injection. Small human trials show it reliably raises NAD+ levels and hint at some metabolic and muscle endpoints, but any effect on human lifespan or aging is unproven. Popularity far outstrips the strength of the outcome data.
The full published spec sheet — dose units, timing, frequency, and cycle length — is included with membership.
The published dose for this compound, shown as reference. Included with membership.
